Mark A. Atkinson

Methods for diagnosis of type 1 diabetes

#2 | 2018-11-01

US20180311344A1

MATERIALS AND METHODS FOR MODULATING IMMUNE RESPONSES

#3 | 2016-07-07

US20160195546A1

Type 1 Diabetes Biomarkers

#4 | 2016-01-28

US20160022793A1

Compositions for treatment and/or prevention of autoimmune disorders

#5 | 2015-05-28

US20150147388A1

Materials and methods for modulating immune responses

#6 | 2014-10-09

US20140301973A1

COMBINATION THERAPIES FOR TREATING TYPE 1 DIABETES

#7 | 2014-09-18

US20140271718A1

NOVEL TYPE 1 DIABETES VACCINES, AND METHODS OF USE

#8 | 2013-10-31

US20130287729A1

Antigen-specific, tolerance-inducing microparticles and uses thereof

#9 | 2012-07-19

US20120183513A1

supplement for alleviating type 1 diabetes

#10 | 2012-03-29

US20120077709A1

Biomarkers for differentiating between type 1 and type 2 diabetes

#11 | 2010-12-23

US20100322894A1

Combination therapies for treating type 1 diabetes

#12 | 2010-07-15

US20100178652A1

Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease

#13 | 2010-07-08

US20100172994A1

Nanoparticles for Protection of Cells from Oxidative Stress

#14 | 2010-05-13

US20100120629A1

Biomarkers for Differentiating Between Type 1 and Type 2 Diabetes

#15 | 2009-06-25

US20090162345A1

Materials and Methods for Reversing Type-1 Diabetes

#16 | 2009-04-30

US20090111766A1

RAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES

#17 | 2007-01-04

US20070003518A1

Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases

#18 | 2006-12-28

US20060292117A1

Improved rAAv vectors

#19 | 2005-03-10

US20050054005A1